nortriptyline has been researched along with Pulmonary Disease, Chronic Obstructive in 13 studies
Nortriptyline: A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions.
nortriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of amitriptyline.
Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bupropion SR treatment is an efficacious aid to smoking cessation in patients with COPD." | 9.11 | Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. ( Huibers, MJ; Knipschild, PG; van Schayck, CP; Wagena, EJ; Wouters, EF, 2005) |
| "A total of 255 participants, aged 30-70 years, received smoking cessation counselling and were assigned bupropion, nortriptyline or placebo randomly for 12 weeks." | 5.14 | The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients. ( Kaper, J; Severens, JL; Van Schayck, CP; Wagena, EJ; Wouters, EF, 2009) |
| "The study design is a randomized controlled trial comparing confrontational counselling delivered by a respiratory nurse combined with nortriptyline for smoking cessation (experimental group), health education and promotion delivered by a respiratory nurse combined with nortriptyline for smoking cessation (control group 1), and "care as usual" delivered by the GP (control group 2)." | 5.12 | Efficacy of confrontational counselling for smoking cessation in smokers with previously undiagnosed mild to moderate airflow limitation: study protocol of a randomized controlled trial. ( Huibers, MJ; Kotz, D; van Schayck, OC; Wesseling, G, 2007) |
| "Bupropion SR treatment is an efficacious aid to smoking cessation in patients with COPD." | 5.11 | Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. ( Huibers, MJ; Knipschild, PG; van Schayck, CP; Wagena, EJ; Wouters, EF, 2005) |
| "However, this major comorbidity in COPD is rarely managed effectively." | 2.58 | Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease. ( Carson-Chahhoud, KV; Pollok, J; van Agteren, JE, 2018) |
| "Patients with COPD show higher nicotine dependence and seem to have greater difficulty in quitting smoking." | 2.47 | [Smoking in COPD]. ( Bernabé Barrios, MJ; Rodríguez Hermosa, JL; Santamaría Rodríguez, B; Zamarro García, C, 2011) |
| "Optimization of NRT is of importance in COPD patients because they may be more nicotine dependent and have more difficulties to quit than smokers without COPD." | 2.45 | Therapeutic strategies to optimize the efficacy of nicotine replacement therapies. ( Berlin, I, 2009) |
| "Pretreatment with nortriptyline inhibited pAkt induced by CSE and H(2)O(2) as well as restored HDAC activity that had been decreased by H(2)O(2) and CSE." | 1.37 | Nortriptyline reverses corticosteroid insensitivity by inhibition of phosphoinositide-3-kinase-δ. ( Barnes, PJ; Ito, K; Mercado, N; To, Y, 2011) |
| "Rehabilitation of COPD-patients is an important part of the therapeutic management." | 1.33 | [COPD-rehabilitation]. ( Lichtenschopf, A; Zwick, H, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Kadushkin, A | 1 |
| Tahanovich, A | 1 |
| Movchan, L | 1 |
| Levandovskaya, O | 1 |
| Shman, T | 1 |
| Kadushkin, AG | 1 |
| Tahanovich, AD | 1 |
| Movchan, LV | 1 |
| Kolesnikova, TS | 1 |
| Khadasouskaya, EV | 1 |
| Shman, TV | 1 |
| van Eerd, EAM | 1 |
| van Schayck, OCP | 1 |
| Wesseling, G | 3 |
| Kotz, D | 3 |
| Pollok, J | 1 |
| van Agteren, JE | 1 |
| Carson-Chahhoud, KV | 1 |
| Huibers, MJ | 3 |
| van Schayck, OC | 2 |
| Bredesen, H | 1 |
| Lous, J | 1 |
| Berlin, I | 1 |
| Van Schayck, CP | 2 |
| Kaper, J | 1 |
| Wagena, EJ | 2 |
| Wouters, EF | 2 |
| Severens, JL | 1 |
| Mercado, N | 1 |
| To, Y | 1 |
| Ito, K | 1 |
| Barnes, PJ | 1 |
| Zamarro García, C | 1 |
| Bernabé Barrios, MJ | 1 |
| Santamaría Rodríguez, B | 1 |
| Rodríguez Hermosa, JL | 1 |
| Zwick, H | 1 |
| Lichtenschopf, A | 1 |
| Knipschild, PG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| In-patient Smoking Cessation Intervention Using Counseling, Spirometry and Nicotine Replacement Therapy[NCT02470923] | 90 participants (Anticipated) | Interventional | 2015-08-31 | Recruiting | |||
| "Effectiveness of the Evaluation and Communication of Pulmonary Age as Help for Smoking Cessation: a Cluster Randomized Essay"[NCT04276116] | 800 participants (Anticipated) | Interventional | 2023-03-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for nortriptyline and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
Topics: Antidepressive Agents, Tricyclic; Depression; Dizziness; Dyspnea; Exercise Tolerance; Forced Expirat | 2018 |
Therapeutic strategies to optimize the efficacy of nicotine replacement therapies.
Topics: Administration, Cutaneous; Administration, Oral; Antidepressive Agents, Second-Generation; Antidepre | 2009 |
[Smoking in COPD].
Topics: Benzazepines; Bupropion; Clonidine; Comorbidity; Disease Progression; Europe; Humans; Motivation; Ni | 2011 |
5 trials available for nortriptyline and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Predictors of long-term smoking cessation in patients with COPD: results from a randomised controlled trial.
Topics: Aged; Female; Humans; Male; Middle Aged; Nortriptyline; Patient Participation; Prevalence; Pulmonary | 2017 |
Efficacy of confronting smokers with airflow limitation for smoking cessation.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Counseling; Female; Humans; Logistic Models; Male; Middle | 2009 |
Efficacy of confronting smokers with airflow limitation for smoking cessation.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Counseling; Female; Humans; Logistic Models; Male; Middle | 2009 |
Efficacy of confronting smokers with airflow limitation for smoking cessation.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Counseling; Female; Humans; Logistic Models; Male; Middle | 2009 |
Efficacy of confronting smokers with airflow limitation for smoking cessation.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Counseling; Female; Humans; Logistic Models; Male; Middle | 2009 |
The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients.
Topics: Adult; Aged; Antidepressive Agents; Bupropion; Confidence Intervals; Cost-Benefit Analysis; Cotinine | 2009 |
Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Depression; D | 2005 |
Efficacy of confrontational counselling for smoking cessation in smokers with previously undiagnosed mild to moderate airflow limitation: study protocol of a randomized controlled trial.
Topics: Adrenergic Uptake Inhibitors; Combined Modality Therapy; Counseling; Humans; Nortriptyline; Patient | 2007 |
5 other studies available for nortriptyline and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Nortriptyline enhances corticosteroid sensitivity of blood T cells from patients with chronic obstructive pulmonary disease.
Topics: Adrenal Cortex Hormones; Humans; Leukocytes, Mononuclear; Nortriptyline; Pulmonary Disease, Chronic | 2021 |
Nortriptyline Modulates the Migration of Peripheral Blood Lymphocytes and Monocytes in Patients with Chronic Obstructive Pulmonary Disease.
Topics: Budesonide; Chemokines; Humans; Killer Cells, Natural; Monocytes; Nortriptyline; Pulmonary Disease, | 2022 |
[Smoking cessation with special focus on primary health care].
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cardiovascula | 2009 |
Nortriptyline reverses corticosteroid insensitivity by inhibition of phosphoinositide-3-kinase-δ.
Topics: Adrenal Cortex Hormones; Adrenergic Uptake Inhibitors; Anti-Inflammatory Agents; Budesonide; Cells, | 2011 |
[COPD-rehabilitation].
Topics: Acupuncture Therapy; Adrenergic alpha-Agonists; Antidepressive Agents, Second-Generation; Antidepres | 2005 |